T1	intervention 52 61	Celecoxib
T2	condition 84 97	Skin Toxicity
T3	eligibility 101 155	Patients Receiving Radiation Therapy for Breast Cancer
T4	No-of-participants 552 557	Sixty
T5	control 635 642	placebo
T6	outcome-Measure 673 701	Radiation-induced dermatitis
T7	outcome-Measure 795 811	pain and itching
T8	outcome-Measure 897 912	Breast swelling
T9	outcome 1056 1112	reduced significantly radiation-induced itching and pain
T10	outcome 1149 1195	reduced the frequency of increased breast size
T11	outcome 1347 1378	insignificantly skin dermatitis
